期刊文献+

重视浆细胞疾病的临床研究 被引量:2

Pay attention to the clinical study of plasma cell disorders
原文传递
导出
摘要 浆细胞病(包括多发性骨髓瘤、意义未明的单克隆免疫球蛋白血症、华氏巨球蛋白血症、淀粉样变性、POEMS综合征等)是血液系统常见的恶性疾病,发病率逐年增高。深入地研究该病的临床过程,制订合理的治疗方法是延长患者生存期,改善预后的重要途径。 Plasma cell dyscrasia including multiple myeloma, monoclonal gammopathy of undetermined significance(MGUS), Waldenstrom' s macroglobulinemia, amyloidosis and POEMS syndrome is a common malignant disease of hematological system and its incidence is increased by year. Deeply study the clinical process of this kind of disease and make reasonable therapies is an important approach for extending the life span and improving the prognosis of patients.
作者 陈世伦
出处 《白血病.淋巴瘤》 CAS 2009年第4期193-194,196,共3页 Journal of Leukemia & Lymphoma
关键词 多发性骨髓瘤 浆细胞 疾病 Multiple myeloma Plasma cells Disease
  • 相关文献

参考文献12

  • 1Jemal A, Murrary T, Ward E, et al. Cancer statistics. CA Cancer J Clin, 2005, 55: 10-30.
  • 2Kyie RA, Rajkuma SV. Drug therapy: multiple myeloma. N Engl J Med, 2004, 351: 1860-1873.
  • 3Durie BG, Harousseau JL, Miguel JS, et al. International uniform response criteria for multipl myeloma. Leukemia, 2006, 20: 2220.
  • 4Lacy MQ, Gertz MA, Dispenzieri A, et al. Long-term results of response to therapy, time to progression and survival with lenalidomide plus dexamethasone in newly diagnosed myeloma. Mayo Clin Proc, 2007, 82: 1179-1184.
  • 5van de Velde HJK, Liu X, Chen G, et al. Complete response correlates with long-term survival and progression-free survival in high-dose therapy in multiple myeloma. Haematologica, 2007, 92: 1399-1406.
  • 6Mateos MV, Hemandez JM, Hernandez MT, et al.Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: results of a muhicenter phase 1/2 study. Blood, 2006, 108: 2165-2172.
  • 7Rajkumar SV, Jacobus S, Callander N, et al. A randomized trial of lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone in newly diagnosed multiple myeloma (E403): a trial coordinated by the Eastern Cooperative Oncology Group. Blood, 2007, 110. Abstract #31.
  • 8Abdelkefi A, Ladeb S, Torjman L, et al. Single autologous stem cell transplantation followed by maintenance therapy with thalidomide is superior to double autologous transplantation in multiple myeloma: results of a muhicenter randomized clinical trial. Blood, 2008, 111: 1805-1810.
  • 9Rajkumr SV, Kyle RA, Therneau TM, et al. Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance. Blood, 2005, 106: 812- 817.
  • 10Ghobrial IM, Witzig TE. Waldenstrom macroglobulinemia. Curr Treat Options Oncol, 2004, 5: 239-247.

同被引文献28

  • 1沈利民,张建富,王永韧,杨慧.130例多发性骨髓瘤临床特点与细胞形态学分析[J].实用医技杂志,2007,14(9):1123-1125. 被引量:4
  • 2何吉琼.多发性骨髓瘤的诊断进展及临床意义[J].现代医药卫生,2005,21(2):163-164. 被引量:5
  • 3申红玉,栾芳,刘华,鞠瑛,郭春,曹英林,马春红.转录抑制因子ZHX2对AFP启动子的抑制作用[J].中华微生物学和免疫学杂志,2007,27(4):311-315. 被引量:3
  • 4郝玉书,王建祥,肖志坚,等.白血病疾病基础理论与临床[M].上海:上海科学技术出版社,2006:711-718.
  • 5Kawata H,Yamada K,Shou Z,et al. The mouse zinc-fingers and homeoboxes (ZHX) family; ZHX2 forms a heterodimer with ZHX3[J].Gene,2003, 323:133-140.
  • 6Kawata H,Yamada K,Shou Z,et al.Zinc-fingers and homeoboxes(ZHX) 2,a novel member of the ZHX family,functions as a transcriptional repressor[J].Biochem J,2003,373(Pt3):747-757.
  • 7Fry CJ,Farnham PJ. Context-dependent transcriptional regulation[J].Biol Chem,1999, 274(42):29583-29586.
  • 8Hu X,Lazar MA. Transcriptional repression by nuclear homone receptors[J].Trends Endocrinol Metab,2000, 11(1):6-10.
  • 9Ngan Vo,Richard H. CREB-binding protein and p300 in transcriptional regulation[J].Biol Chem,2001, 276(17):13505-13508.
  • 10Morford LA,Davis C,Jin L,et al. The oncofetal gene glypican 3 is regulated in the postnatal liver by zinc fingers and homeoboxes 2 and in the regenerating liver by alpha-fetoprotein regulator 2[J].Hepatology,2007, 46(5):1541-1547.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部